Using Kinect Motion Capture to Measure Shoulder Motion in Patients Undergoing Capsular Distension for Adhesive Capsulitis


This study will compare shoulder range of motion assessment using the Kinect motion tracking system vs goniometer in patients with adhesive capsulitis (frozen shoulder) undergoing ultrasound-guided capsular distention procedures (standard of care).

The investigators hypothesize that, for shoulder adhesive capsulitis, the Kinect Motion Analysis 2.0 system will provide reliable results in a shorter and more efficient amount of time in comparison to traditional goniometer methods.

Full Title of Study: “Measurement of Shoulder Range of Motion Using Microsoft Kinect 2.0 in Patients Undergoing Ultrasound-guided Capsular Distension for Adhesive Capsulitis”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 1, 2021

Detailed Description

The study will be a single-center, investigator-initiated protocol to assess the reliability of the Kinect Motion Analysis 2.0 Motion Tracking System for Range Of Motion (ROM) assessment in patients with Shoulder Adhesive Capsulitis undergoing ultrasound guided capsular distention procedures (standard of care for adhesive capsulitis). Secondarily, the study will describe the relationship between range of motion of the shoulder girdle in the four quadrants of normalized reachable workspace by the Kinect 2.0, PROMIS person-reported outcome scores for pain, pain interference and function (general mobility and upper extremity function), and VAS pain scores.

Study participants are anticipated to remain in the study for 12 weeks: an initial visit followed by 6- and 12-week follow up visits. Given the nature of scheduling appointments in medical clinics, 12 weeks is an approximation; the actual duration may occasionally be 1-2 weeks longer if needed to successfully complete the follow-up visit.

The investigators hypothesize that, for shoulder adhesive capsulitis, the Kinect Motion Analysis 2.0 system will provide reliable results in a shorter and more efficient amount of time in comparison to traditional goniometer methods.


  • Other: Kinect motion tracking system
    • Kinect motion tracking system is used to measure shoulder range of motion compared to goniometric measurement.

Arms, Groups and Cohorts

  • Other: measurement before and after capsular distention

Clinical Trial Outcome Measures

Primary Measures

  • change in shoulder range of motion
    • Time Frame: 12 weeks
    • measured in degrees (high number of degrees = better range of motion)

Secondary Measures

  • PROMIS score – upper extremity
    • Time Frame: 12 weeks
    • Patient-Reported Outcomes Measurement Information System (PROMIS) is a validated, 46-item, self-reported system to assess physical function and symptoms in patients with disorders of the limb. Range of possible values: 46-230. (Higher score indicates higher function and outcomes)
  • DASH score
    • Time Frame: 12 weeks
    • The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 38-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. Range of possible values: 38-150. (Lower score indicates better function / less disability)
  • VAS score
    • Time Frame: 12 weeks
    • Visual analog scale is a validated, subjective measure for pain. Range of possible values: 0-10. (Higher score indicates more pain)

Participating in This Clinical Trial

Inclusion Criteria

1. diagnosis of limited ROM due to adhesive capsulitis

2. duration of symptoms of ≥ 3 months

3. persistent functional limitation (defined as either limitations occupationally, in independent activities of daily living, or activities of daily living)

4. X-rays and MRI excluding alternative diagnosis

5. age 18 years or older.

Exclusion Criteria

1. prior shoulder surgery on the affected side

2. complete rotator cuff tear (based on clinical history, examination, and imaging) or planned surgical intervention on the affected side

3. ipsilateral subacromial injection within the last 3 months

4. autoimmune or rheumatologic disease affecting the joints

5. lack of scheduled same-day physical therapy appointment

6. inability to complete follow-up appointments or surveys

7. inability to provide informed consent

8. symptomatic glenohumeral or acromioclavicular pathology

9. referred pain from the neck or internal organs

10. generalized myofascial pain syndrome

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University of California, Davis
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Brian Davis, MD, Principal Investigator, UC Davis Health
  • Overall Contact(s)
    • Dana Sheng, MD, 916-734-5292, DLSHENG@UCDAVIS.EDU

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.